Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Patient Information Leaflet last updated on the eMC: 07/09/2011
PIL Lioresal Liquid

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 13/06/2011 and displayed until 07/09/2011
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to warnings or special precautions for use
Updated on 24/05/2011 and displayed until 13/06/2011
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to warnings or special precautions for use
  • PIL Submitted in error
Updated on 06/08/2009 and displayed until 24/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to dosage and administration
Updated on 14/08/2008 and displayed until 06/08/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 11/03/2003 and displayed until 14/08/2008
Reasons for adding or updating:
  • Update to PIL
Updated on 19/12/2001 and displayed until 11/03/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 14/11/2001 and displayed until 19/12/2001
Reasons for adding or updating:
  • Update to PIL
Updated on 14/11/2000 and displayed until 14/11/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   baclofen